Page last updated: 2024-10-25

cyclopenthiazide and Obesity

cyclopenthiazide has been researched along with Obesity in 3 studies

Cyclopenthiazide: Thiazide diuretic also used as an antihypertensive agent.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DE VITA, JA1
WASSERMAN, U1
KAEDING, A1
KLINKMANN, H1

Other Studies

3 other studies available for cyclopenthiazide and Obesity

ArticleYear
[Use of a new saluretic in the treatment of obesity:cyclopenthiazide].
    El Dia medico, 1961, Dec-04, Volume: 33

    Topics: Chlorothiazide; Cyclopenthiazide; Diuretics; Obesity

1961
[Treatment of obesity by means of a new salidiuretic: cyclopenthiazide].
    La Semana medica, 1961, Sep-11, Volume: 119

    Topics: Chlorothiazide; Cyclopenthiazide; Obesity

1961
[ON CYCLOPENTHIAZIDE (AWD-DRESDEN) THERAPY].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1964, Oct-01, Volume: 19

    Topics: Benzothiadiazines; Cyclopenthiazide; Diuretics; Drug Therapy; Edema; Heart Failure; Hyperglycemia; H

1964